Harvard Management Company’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-400,000
| Closed | -$724K | – | 34 |
|
|
2023
Q2 | $724K | Hold |
400,000
| – | – | 0.07% | 29 |
|
|
2023
Q1 | $528K | Hold |
400,000
| – | – | 0.06% | 45 |
|
|
2022
Q4 | $676K | Hold |
400,000
| – | – | 0.08% | 42 |
|
|
2022
Q3 | $740K | Hold |
400,000
| – | – | 0.09% | 45 |
|
|
2022
Q2 | $1.23M | Hold |
400,000
| – | – | 0.14% | 38 |
|
|
2022
Q1 | $2.89M | Hold |
400,000
| – | – | 0.29% | 35 |
|
|
2021
Q4 | $6.55M | Hold |
400,000
| – | – | 0.61% | 36 |
|
|
2021
Q3 | $3.98M | Hold |
400,000
| – | – | 0.23% | 31 |
|
|
2021
Q2 | $4M | Hold |
400,000
| – | – | 0.23% | 29 |
|
|
2021
Q1 | $3.98M | Buy |
+400,000
| New | +$3.98M | 0.22% | 32 |
|